<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03896763</url>
  </required_header>
  <id_info>
    <org_study_id>831295</org_study_id>
    <nct_id>NCT03896763</nct_id>
  </id_info>
  <brief_title>PROSpect: Prone and Oscillation Pediatric Clinical Trial</brief_title>
  <official_title>PROSpect: Prone and Oscillation Pediatric Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Medical Center Groningen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Boston Children’s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Severe pediatric acute respiratory distress syndrome (PARDS) is a life-threatening and
      frequent problem experienced by thousands of children each year. Little evidence supports
      current supportive practices during their critical illness. The overall objective of this
      study is to identify the best positional and/or ventilation practice that leads to improved
      patient outcomes in these critically ill children. We hypothesize that children with severe
      PARDS treated with either prone positioning or high-frequency oscillatory ventilation (HFOV)
      will demonstrate more days off the ventilator when compared to children treated with supine
      positioning or conventional mechanical ventilation (CMV).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PROSpect is a two-by-two factorial, response-adaptive, randomized controlled clinical trial
      of supine/prone positioning and conventional mechanical ventilation (CMV)/high-frequency
      oscillatory ventilation (HFOV). About 45 pediatric intensive care units (PICUs), 30 U.S. and
      15 international, with at least 5 years of experience with prone positioning and HFOV in the
      care of pediatric patients with severe Pediatric Acute Respiratory Distress Syndrome (PARDS),
      that can provide back-up extracorporeal membrane oxygenation (ECMO) support, are
      participating. Eligible consecutive subjects with severe PARDS will be randomized to one of
      four groups: supine/CMV, prone/CMV, supine/HFOV, prone/HFOV. Subjects who fail their assigned
      positional and/or ventilation therapy for either persistent hypoxia or hypercapnia may
      receive the reciprocal therapy while being considered for ECMO cannulation. Our primary
      outcome is ventilator-free days (VFD) through day 28, where non-survivors receive zero VFD.
      We hypothesize that children with severe PARDS treated with either prone positioning or HFOV
      will demonstrate ≥ 2 more VFD. Our secondary outcome is nonpulmonary organ failure-free days.
      We will also explore the interaction effects of prone positioning with HFOV on VFDs and also
      investigate the impact of these interventions on 90-day in-hospital mortality and, among
      survivors, the duration of mechanical ventilation, PICU and hospital length of stay, and the
      trajectory of post-PICU functional status and health-related quality of life (HRQL). Up to
      1000 subjects with severe PARDS will be randomized, stratified by age group and
      direct/indirect lung injury. Adaptive randomization will first occur after 400 patients are
      randomized and have been followed for 28 days, and every 100 patients thereafter. At these
      randomization update analyses, new allocation probabilities will be computed based on ongoing
      intention-to-treat trial results, increasing allocation to well performing arms and
      decreasing allocation to poorly performing arms. Data will be analyzed per intention-to-treat
      for the primary analyses and per-protocol received for primary, secondary and exploratory
      analyses.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 1, 2019</start_date>
  <completion_date type="Anticipated">May 2024</completion_date>
  <primary_completion_date type="Anticipated">May 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <intervention_model_description>Two-by-two factorial, response-adaptive, randomized controlled clinical trial</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ventilator-free Days (VFD)</measure>
    <time_frame>28 days</time_frame>
    <description>Our primary research hypothesis is that children with severe PARDS randomized to either prone positioning or HFOV will demonstrate more ventilator-free days. We hypothesize that a superior treatment would improve VFD by at least 2 days, a clinically meaningful difference. VFD is the number of days within 28 days that a patient is alive and free of mechanical ventilation. Improvement in VFD will be considered within the context of patient safety; specifically, patients must also exhibit a similar safety profile.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Nonpulmonary organ failure-free days (OFFD)</measure>
    <time_frame>28 days</time_frame>
    <description>Our secondary research hypothesis is that children with severe PARDS randomized to either prone positioning or HFOV will demonstrate more more nonpulmonary organ failure-free days. OFFD is the number of days within 28 days that a patient is alive and free of clinically significant non-pulmonary organ failure. Nonpulmonary organ failure-free days will be calculated based on the clinically important nonpulmonary organ systems (neurologic, cardiovascular, renal and hematologic) using nonpulmonary PEdiatric Logistic Organ Dysfunction-2 (PELOD-20 scores.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Interaction effects of prone positioning with HFOV on VFDs - number of ventilator-free days</measure>
    <time_frame>28 days</time_frame>
    <description>The number of ventilator-free days (VFD) will be compared between children randomized to prone/CMV and supine/HFOV to those randomized to prone/HFOV. VFD is the number of days within 28 days that a patient is alive and free of mechanical ventilation.</description>
  </other_outcome>
  <other_outcome>
    <measure>90-day in-hospital mortality</measure>
    <time_frame>90 days</time_frame>
    <description>Deaths from all causes will be monitored through hospital discharge or day 90 (whichever occurs first). The primary and secondary causes of death (as specified on the death certificate) will be recorded to allow us to probe the cause of death in PARDS.</description>
  </other_outcome>
  <other_outcome>
    <measure>Duration of mechanical ventilation (among survivors)</measure>
    <time_frame>28 days, 90 days</time_frame>
    <description>Duration of mechanical ventilation provides a prospective evaluation of ventilator support independent of mortality. The duration of mechanical ventilation is defined as the time from day 0 (intubation) to the first time the endotracheal tube is continuously absent for at least 24 hours. For subjects with tracheostomies, duration of mechanical ventilation is defined as the time of initiation of assisted breathing to the first time positive pressure is &lt;5 cm H2O (continuous or bi-level) for at least 24 hours. Duration of mechanical ventilation will be considered to be 28 days for subjects still intubated on day 28, and will be calculated for subjects who survive to hospital discharge or day 90 (whichever occurs first).</description>
  </other_outcome>
  <other_outcome>
    <measure>PICU and hospital length of stay (among survivors)</measure>
    <time_frame>90 days</time_frame>
    <description>PICU length of stay (LOS) is defined as the time from day 0 (intubation) to the time of PICU discharge, while hospital LOS is defined as the time from day 0 to the time of hospital discharge. PICU and hospital LOS will be considered to be 90 days for subjects still in the PICU/hospital on day 90, and will be calculated for subjects who survive to hospital discharge or day 90 (whichever occurs first).</description>
  </other_outcome>
  <other_outcome>
    <measure>Post PICU discharge functional status</measure>
    <time_frame>1, 3, 6, 12 months post PICU discharge</time_frame>
    <description>Pre and post PICU functional status will be compared. Functional status will be assessed using the Pediatric Cerebral Performance (PCPC), Pediatric Overall Performance Category (POPC) and Functional Status Scale (FSS) score. The PCPC and POPC quantify short-term cognitive impairments and functional morbidity. Scores range from 1 to 6 for both scales with 1: good, 2: mild disability, and 6: brain death. The FSS is a valid and reliable assessment method to quantify functional status. The FSS includes 6 domains: mental status, sensory functioning, communication, motor function, feeding, and respiratory. Scores for each domain range from 1 (normal) to 5 (very severe dysfunction) with total scores ranging from 6 to 30.</description>
  </other_outcome>
  <other_outcome>
    <measure>Post PICU discharge health-related quality of life (HRQL)</measure>
    <time_frame>1, 3, 6, 12 months post PICU discharge</time_frame>
    <description>Pre and post PICU health-related quality of life will be compared using the PedsQL 4.0 Generic Core Scales and Infant Scales - Acute Version They are 23-item child self-report and parent proxy-report scales with four domains: physical functioning, emotional functioning, social functioning, and school functioning. Scale ranges from 0 to 100, with higher scores indicating fewer problems. The PedsQL Infant Scales consist of 36-45 questions, depending on age, with 5 domains: physical functioning, physical symptoms, emotional functioning, social functioning, and cognitive functioning. The PedsQL™ Multi-dimensional Fatigue Scale - Acute Version is an 18-item scale that encompasses three domains: General Fatigue, Sleep/Rest Fatigue and Cognitive Fatigue. Higher scores indicate better HRQOL. PedsQL Pediatric Pain Questionnaire is a generic pain instrument. Subjects capable of self-reporting identify a point on a 100 mm line that best shows the worst pain they experienced in the past week.</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Acute Respiratory Distress Syndrome in Children</condition>
  <arm_group>
    <arm_group_label>Supine / CMV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supine positioning and conventional mechanical ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prone / CMV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prone positioning and conventional mechanical ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Supine / HVOF</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Supine positioning and high-frequency oscillatory ventilation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Prone / HFOV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prone positioning and high-frequency oscillatory ventilation</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Either supine or prone positioning and either CMV or HFOV</intervention_name>
    <description>Supine positioning: Subjects randomized to supine positioning will remain supine.
Prone positioning: Subjects randomized to prone positioning will be positioned prone ≥16 hours/day for a maximum of 28 days.
CMV strategy: Low tidal volume to obtain exhaled Vt of 5-7 ml/kg (ideal body weight), PIP goal limited to ≤ 28 cm H2O and lung recruitment maneuver to identify best PEEP then maintained per PEEP-FiO2 grid.
HFOV strategy: Frequency at 8-12 Hz, amplitude (delta-P) 60-90 and mPaw recruitment maneuver.</description>
    <arm_group_label>Prone / CMV</arm_group_label>
    <arm_group_label>Prone / HFOV</arm_group_label>
    <arm_group_label>Supine / CMV</arm_group_label>
    <arm_group_label>Supine / HVOF</arm_group_label>
    <other_name>Supine positioning</other_name>
    <other_name>Prone positioing</other_name>
    <other_name>Conventional mechanical ventilation (CMV)</other_name>
    <other_name>High frequency oscillatory ventilation (HFOV)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion criteria:

        Intubated and mechanically ventilated with moderate-severe PARDS for &lt;48 hours per PALICC
        guidelines (chest imaging consistent with acute pulmonary parenchymal disease and OI ≥12 or
        OSI ≥10). We require two blood gases meeting moderate-severe PARDS criteria (separated by
        at least 4 ± 2 hours during which time the clinical team is actively working to recruit
        lung volume and optimize the patient's hemodynamic status per PALICC guidelines;
        specifically, incremental and decremental PEEP changes to optimize lung volume). A second
        blood gas is not required for OI ≥16.

        Exclusion criteria:

          -  Perinatal related lung disease

          -  Congenital diaphragmatic hernia or congenital/acquired diaphragm paralysis

          -  Respiratory failure explained by cardiac failure or fluid overload

          -  Cyanotic heart disease

          -  Cardiomyopathy

          -  Unilateral lung disease

          -  Primary pulmonary hypertension

          -  Intubated for status asthmaticus

          -  Obstructive airway disease (e.g., Severe airways disease without parenchymal
             involvement or disease characterized by hypercapnia with FiO2 &lt;0.30 and/or evidence of
             increased resistance visible on the flow - time scalar and/or presence of intrinsic
             PEEP)

          -  Active air leak

          -  Bronchiolitis obliterans

          -  Post hematopoietic stem cell transplant; specifically, patients receiving continuous
             supplemental oxygen for three or more days prior to intubation; receiving noninvasive
             ventilation for more than 24 hours prior to intubation; receiving more than one
             vasoactive medication at time of meeting inclusion criteria; spending more than four
             days in the PICU prior to intubation; supported on or with immediate plans for renal
             replacement therapies; with two or more allogeneic transplants; who relapsed after the
             transplant; or with diffuse alveolar hemorrhage

          -  Post lung transplant

          -  Home ventilator (including noninvasive) or home oxygen dependent (exception:
             night-time noninvasive ventilation (CPAP/BiPAP) or oxygen for obstructive sleep apnea
             is permitted)

          -  Neuromuscular respiratory failure

          -  Critical airway (e.g., post laryngotracheal surgery or new tracheostomy) or anatomical
             obstruction of the lower airway (e.g., mediastinal mass)

          -  Facial surgery or trauma in previous 2 weeks

          -  Head trauma (managed with hyperventilation)

          -  Intracranial bleeding

          -  Unstable spine, femur or pelvic fractures

          -  Acute abdominal process/open abdomen

          -  Morbid obesity (2w-24 months: WHO weight-for-length/height z-score ≥+3; ≥2 years: WHO
             body mass index (BMI)-for-age z-score ≥+3)

          -  Currently receiving either prone positioning or any high-frequency mode of MV with
             current illness (Up to 4 hours of prone positioning and/or any mode of high-frequency
             mode of MV is allowed as long as the therapies are off for least 4 hours prior to the
             subject meeting oxygenation criteria.)

          -  Supported on ECMO during the current admission

          -  Family/medical team not providing full support (patient treatment considered futile)

          -  Previously enrolled in current study

          -  Enrolled in any other interventional clinical trial not approved for co-enrollment

          -  Known pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martha AQ Curley, RN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pennsylvania</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ira M. Cheifetz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Duke University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Martin CJ Kneyber, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beatrix Children's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Wypij, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Children’s Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Amy Cassidy</last_name>
    <phone>215-898-4151</phone>
    <email>acassidy@nursing.upenn.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Children's of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele Kong, MD</last_name>
      <email>mkong@peds.uab.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Phoenix Children's Hospital</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85016</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erin Kreml, MD</last_name>
      <email>ekreml@phoenixchildrens.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Olivia K Irby, MD</last_name>
      <email>okvaden@uams.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Orange County</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adam Schwarz, MD</last_name>
      <email>aschwarz@choc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UC Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Constantine Dimitriades, MD</last_name>
      <email>cdimitriades@ucdavis.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UCSF Benioff Children's</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shan Ward, MD</last_name>
      <email>shan.ward@ucsf.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Connecticut Children's Medical Center</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allison Cowl, MD</last_name>
      <email>acowl@connecticutchildrens.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Yale University</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josep Panisello, MD</last_name>
      <email>josep.panisello@yale.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nemours Foundation</name>
      <address>
        <city>Wilmington</city>
        <state>Delaware</state>
        <zip>19803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kimberly McMahon, MD</last_name>
      <email>kimberly.mcmahon@nemours.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>UF Shangs Children's Hospital</name>
      <address>
        <city>Gainesville</city>
        <state>Florida</state>
        <zip>32610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Leslie Avery, MD</last_name>
      <email>avery4@ufl.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Holtz Children's Hospital</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gwenn E McLaughlin, MD</last_name>
      <email>gmclaugh@med.miami.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bria Coates, MD</last_name>
      <email>b-coates@northwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children at IU Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Courtney Rowan, MD</last_name>
      <email>coujohns@iu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Iowa Stead Family Chlldren's Hospital</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kari Wellnitz, MD</last_name>
      <email>kari-wellnitz@uiowa.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Norton Children's Hospital</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Melissa Porter, MD</last_name>
      <email>mbport04@exchange.lousville.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Maryland Medical Center-Children's Hospital</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ana Lia Graciano, MD</last_name>
      <email>agraciano@som.umaryland.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Bloomberg Children's Center, Johns Hopkins University</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21287</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sapna Kudchadkar, MD</last_name>
      <email>skudcha1@jhmi.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CS Mott Children's Hospital</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Flori, MD</last_name>
      <email>heidiflo@med.umich.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital and Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siharth Mahapatra, MD</last_name>
      <email>smahapatra@childrensomaha.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Children's Hospital of Montefiore</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Derespina, MD</last_name>
      <email>kderespi@montefiore.org</email>
    </contact>
    <contact_backup>
      <last_name>Subhi Kaushik, MD</last_name>
      <email>skaushik@montefiore.org</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>UNC Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katherine Clement, MD</last_name>
      <email>katherine_clement@med.unc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Duke Children's Hospital</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27710</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Palen Mallory, MD</last_name>
      <email>palen.powelson@duke.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ranjit Chima, MD</last_name>
      <email>ranjit.chima@cchmc.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital at Oklahoma University Medical Center</name>
      <address>
        <city>Oklahoma City</city>
        <state>Oklahoma</state>
        <zip>73104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emilie Henry, MD</last_name>
      <email>emilie-henry@ouhsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Penn State Children's Hospital</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Neal J Thomas, MD</last_name>
      <email>njthomas@psu.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Philadelphia</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19014</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nadir Yehya, MD</last_name>
      <email>yehyan@email.chop.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>LeBonheur Children's Hospital</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hitesh Singh Sandhu, MD</last_name>
      <email>hsandhu@uthsc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medical City Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kris G Bysani, MD</last_name>
      <email>gbysani@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Health Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Luckett, MD</last_name>
      <email>peter.uckett@utsouthwestern.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Medical Center Dallas</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75235</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Luckett, MD</last_name>
      <email>peter.luckett@utsouthwesternn.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of San Antonio</name>
      <address>
        <city>San Antonio</city>
        <state>Texas</state>
        <zip>78207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matei Petrescu, MD</last_name>
      <email>matei.petrescu@bcm.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital at Richmond at VCU</name>
      <address>
        <city>Richmond</city>
        <state>Virginia</state>
        <zip>23219</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jesse Bain, DO</last_name>
      <email>jesse.bain@vcuhealth.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seattle Children's</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lincoln Smith, MD</last_name>
      <email>lincolns@uw.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital of Wisconsin</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Gedeit, MD</last_name>
      <email>rgedeit@mcw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jasmine Dowell, MD</last_name>
      <email>jdowell@mcw.edu</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Perth Children's Hospital</name>
      <address>
        <city>Perth</city>
        <state>Western Australia</state>
        <zip>6840</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Simon Erickson, MD</last_name>
      <email>simon.erickson@health.wa.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's hospital at Westmead</name>
      <address>
        <city>Sydney</city>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jonathan Egan, MD</last_name>
      <email>jonathan.egan@health.nsw.gov.au</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Alberta Children's Hospital</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3B6A8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurie Lee, NP</last_name>
      <email>laurie.lee@albertahealthservices.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Sainte Justine</name>
      <address>
        <city>Montréal</city>
        <state>Quebec</state>
        <zip>H3T1C5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Emeriaud, MD</last_name>
      <email>guillaume.emeriaud@umontreal.ca</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Malaysia Medical Center</name>
      <address>
        <city>Kuala Lumpur</city>
        <country>Malaysia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chin Seng Gan, MD</last_name>
      <email>csgan@ummc.edu.my</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Kneyber, MD</last_name>
      <email>m.c.j.kneyber@umcg.nl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>King Chulalongkorn Memorial Hospital</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rujipat Samransamruajkit, MD</last_name>
      <email>rujipat.s@chula.ac.th</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine Siriraj Hospital, Mahidol University</name>
      <address>
        <city>Bangkok</city>
        <zip>10700</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Suwannee Phumeetham, MD</last_name>
      <email>suwannee.phu@mahidol.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Faculty of Medicine Ramathibodi Hospital</name>
      <address>
        <city>Bangkok</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nattachai Anantasit, MD</last_name>
      <email>nattachai032@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Malaysia</country>
    <country>Netherlands</country>
    <country>Thailand</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.prospect-network.org/</url>
    <description>Study Website</description>
  </link>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>October 22, 2018</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 1, 2019</study_first_posted>
  <last_update_submitted>June 30, 2020</last_update_submitted>
  <last_update_submitted_qc>June 30, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Pennsylvania</investigator_affiliation>
    <investigator_full_name>Martha A.Q. Curley, PhD, RN</investigator_full_name>
    <investigator_title>Ruth M. Colket Endowed Chair in Pediatric Nursing</investigator_title>
  </responsible_party>
  <keyword>Pediatric Acute Respiratory Distress Syndrome (PARDS)</keyword>
  <keyword>Acute Respiratory Distress Syndrome (ARDS)</keyword>
  <keyword>acute respiratory failure</keyword>
  <keyword>child</keyword>
  <keyword>pediatric intensive care unit</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Per NHLBI policy, we will provide a deidentified dataset and all the data-related documentation necessary to utilize the study data (dictionary, calculated variables and standard operating procedures) to the NHLBI. We will submit this dataset to the NHLBI Data Repository managed by the BioLINCC (Biologic Specimen and Data Repository Information Coordinating Center).</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>3 years after the final follow-up interview or 2 years after the primary paper has been published, whichever comes first.</ipd_time_frame>
    <ipd_access_criteria>Subject to the approval of the (1) PROSpect Ancillary Study Committee, (2) PROSpect Executive Committee, and (3) National Heart, Lung, and Blood Institute (NHLBI).</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 17, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03896763/SAP_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>March 22, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03896763/ICF_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>May 1, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03896763/Prot_003.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

